- Home
- INGN vs GOSS Comparison
INGN vs GOSS Comparison
Compare INGN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- GOSS
- Stock Information
- Founded
- INGN 2001
- GOSS 2015
- Country
- INGN United States
- GOSS United States
- Employees
- INGN N/A
- GOSS N/A
- Industry
- INGN Industrial Specialties
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- INGN Health Care
- GOSS Health Care
- Exchange
- INGN Nasdaq
- GOSS Nasdaq
- Market Cap
- INGN 226.5M
- GOSS 237.9M
- IPO Year
- INGN 2014
- GOSS 2019
- Fundamental
- Price
- INGN $10.47
- GOSS $0.96
- Analyst Decision
- INGN Hold
- GOSS Strong Buy
- Analyst Count
- INGN 3
- GOSS 5
- Target Price
- INGN $7.00
- GOSS $9.20
- AVG Volume (30 Days)
- INGN 180.2K
- GOSS 1.0M
- Earning Date
- INGN 02-25-2025
- GOSS 03-04-2025
- Dividend Yield
- INGN N/A
- GOSS N/A
- EPS Growth
- INGN N/A
- GOSS N/A
- EPS
- INGN N/A
- GOSS N/A
- Revenue
- INGN $331,520,000.00
- GOSS $105,322,000.00
- Revenue This Year
- INGN $6.51
- GOSS N/A
- Revenue Next Year
- INGN $4.55
- GOSS N/A
- P/E Ratio
- INGN N/A
- GOSS N/A
- Revenue Growth
- INGN 1.12
- GOSS N/A
- 52 Week Low
- INGN $5.08
- GOSS $0.50
- 52 Week High
- INGN $13.33
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- INGN 62.84
- GOSS 54.23
- Support Level
- INGN $9.25
- GOSS $0.83
- Resistance Level
- INGN $11.62
- GOSS $1.18
- Average True Range (ATR)
- INGN 0.53
- GOSS 0.10
- MACD
- INGN 0.18
- GOSS -0.01
- Stochastic Oscillator
- INGN 64.51
- GOSS 41.37
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.